Mineralys Therapeutics, Inc. (MLYS)
25.86
-0.73
(-2.75%)
USD |
NASDAQ |
Sep 25, 16:00
25.88
+0.02
(+0.08%)
After-Hours: 19:59
Mineralys Therapeutics Market Cap : 2.285B for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 2.285B |
| September 24, 2026 | 2.349B |
| September 23, 2026 | 2.376B |
| September 22, 2026 | 2.598B |
| September 21, 2026 | 2.501B |
| September 18, 2026 | 2.476B |
| September 17, 2026 | 2.472B |
| September 16, 2026 | 2.433B |
| September 15, 2026 | 2.554B |
| September 14, 2026 | 2.558B |
| September 11, 2026 | 2.492B |
| September 10, 2026 | 2.589B |
| September 09, 2026 | 2.695B |
| September 08, 2026 | 2.749B |
| September 04, 2026 | 2.492B |
| September 03, 2026 | 2.498B |
| September 02, 2026 | 2.566B |
| September 01, 2026 | 2.259B |
| August 31, 2026 | 2.268B |
| August 28, 2026 | 2.262B |
| August 27, 2026 | 2.298B |
| August 26, 2026 | 2.287B |
| August 25, 2026 | 2.327B |
| August 24, 2026 | 2.233B |
| August 21, 2026 | 2.266B |
| Date | Value |
|---|---|
| August 20, 2026 | 2.275B |
| August 19, 2026 | 2.381B |
| August 18, 2026 | 2.351B |
| August 17, 2026 | 2.302B |
| August 14, 2026 | 2.265B |
| August 13, 2026 | 2.305B |
| August 12, 2026 | 2.390B |
| August 11, 2026 | 2.415B |
| August 10, 2026 | 2.419B |
| August 07, 2026 | 2.416B |
| August 06, 2026 | 2.225B |
| August 05, 2026 | 2.214B |
| August 04, 2026 | 2.185B |
| August 03, 2026 | 2.126B |
| July 31, 2026 | 2.104B |
| July 30, 2026 | 2.159B |
| July 29, 2026 | 2.173B |
| July 28, 2026 | 2.222B |
| July 27, 2026 | 2.244B |
| July 24, 2026 | 2.202B |
| July 23, 2026 | 2.226B |
| July 22, 2026 | 2.227B |
| July 21, 2026 | 2.269B |
| July 20, 2026 | 2.202B |
| July 17, 2026 | 2.234B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.304B |
| Oncolytics Biotech, Inc. | 85.16M |
| Sangamo Therapeutics, Inc. | 59.66M |
| Sarepta Therapeutics, Inc. | 1.972B |
| Anixa Biosciences, Inc. | 96.14M |
Market Cap Related Metrics
| PEG Ratio | -0.3206 |
| Price to Book Value | 4.147 |
| Price | 25.86 |
| Earnings Yield | -16.41% |
| PEGY Ratio | -0.3206 |